Veritas Genetics Lands $30M for $1,000 Genome Sequencing

Oct 18, 2016, 10:50 AM by Michael Croft

Xconomy | Veritas Genetics, which sells genome sequencing and genetic screening tests, has received a $30 million Series B round of funding to add more products, build out its digital tools for consumers, and ink partnerships with hospitals and researchers around the world.

October 18, 2016 | Veritas Genetics has received a $30 million Series B round of funding to add more products, build out its digital tools for consumers, and ink partnerships with hospitals and researchers around the world. Veritas has also hired 3 new executives to handle each of those endeavors. Bio-IT World featured a profile of Veritas earlier this year. Xconomy